Dren Bio
- Health & Biotech
- San Carlos, California, US
- Founded 2019
- Private
- drenbio.com
Clinical-stage biotech developing antibodies that deplete disease-causing cells, for oncology, hematology and autoimmune disease.
$350MEquity raised in 2025–20262025 — · 2026 $350M · 1 equity round
$475MEquity raised, all time3 equity rounds on record
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 3 rounds · 1 source · newest first
- Private financingAmount$350MPost-money—✓ Confirmed
- Series BAmount$65MPost-money—✓ Confirmed
- Series AAmount$60MPost-money—✓ Confirmed
Investors 17
- HBM Healthcare Investments3
- SR One3
- Taiho Ventures3
- Aisling Capital2
- Juvia Group1
- Lightspeed Venture Partners1
- 8VC3
- BVF Partners3
- Mission BioCapital3
- Alexandria Venture Investments2
- ArrowMark Partners2
- Cormorant Asset Management
- General Catalyst
- Mirae Asset
- OrbiMed
- Pfizer
- Revelation Partners
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
CognitionAI Apps · $3.4B in 2025–2026Shared: 8VC, Lightspeed Venture Partners +1Mistral AIAI Labs · $5.5B in 2025–2026Shared: Lightspeed Venture Partners, General CatalystRampFintech · $3.6B in 2025–2026Shared: 8VC, Lightspeed Venture Partners +1Beacon SoftwareAI Apps · $675M in 2025–2026Shared: Lightspeed Venture Partners, General CatalystAnthropicAI Labs · $113B in 2025–2026Shared: Lightspeed Venture Partners, General CatalystSaronicDefense · $2.4B in 2025–2026Shared: 8VC, Lightspeed Venture Partners +1
Also in the San Carlos hub see on the globe
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Dren Bio and its logo are trademarks of their owners, used here for identification only.
